Welcome to our dedicated page for Red Violet SEC filings (Ticker: RDVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Red Violet, Inc.'s SEC filings document the reporting record of an analytics and information solutions company focused on identity intelligence. Form 8-K filings furnish quarterly and annual earnings releases, conference call transcripts and related exhibits covering operating results and financial condition. Other 8-K disclosures address Regulation FD materials, management agreements and capital allocation actions such as the company's stock repurchase program.
Red Violet proxy filings cover public-company governance, executive compensation, equity awards and related compensation disclosures. Together, the filings describe the company's formal reporting around its CORE™ identity intelligence business, governance framework, executive arrangements, capital structure activity and material corporate events.
Red Violet (RDVT) President James Reilly reported multiple open‑market sales of common stock. Tranches executed from November 10–13, 2025 included 733 shares at a weighted average price of $58.81; 6,273 at $58.03; 2,184 at $57.81; 651 at $58.10; 3,448 at $57.80; 445 at $57.57; and 1,266 at $56.73. Following these transactions, he beneficially owned 231,078 shares directly.
The reported holdings include 26,666 RSUs granted November 30, 2023 (vesting December 1, 2025 and December 1, 2026) and 21,000 RSUs granted November 4, 2024 (vesting November 1, 2026 and November 1, 2027).
Red Violet, Inc. furnished, under Regulation FD, a press release and a conference call transcript announcing financial results for the third quarter ended September 30, 2025. The company issued the materials on November 5, 2025 and provided the transcript as Exhibit 99.1.
The furnished information, including Exhibit 99.1, is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated. An Inline XBRL cover page (Exhibit 104) accompanies the filing.
Red Violet, Inc. (RDVT) reported strong Q3 performance. Revenue rose to $23.1 million, up 21% year over year, while net income increased to $4.2 million, up 145%. Diluted EPS was $0.29. Adjusted EBITDA reached $9.0 million with a 39% margin, reflecting operating leverage as gross margin improved to 73%.
Cash and cash equivalents were $45.4 million as of September 30, 2025. Operating cash flow for the quarter was $10.2 million, and for the nine months it was $22.7 million. The company paid a special cash dividend of $0.30 per share in February and repurchased 15,437 shares in Q3. The board expanded the stock repurchase authorization to $30.0 million, with $18.9 million remaining.
Customer metrics expanded: IDI billable customers reached 9,853 and FOREWARN users 372,209. The company disclosed total commitments of $44.9 million under data licensing and cloud agreements and noted an ongoing Daniel’s Law legal action in New Jersey; the insurer has been notified and coverage is anticipated, subject to limits.
Red Violet, Inc. (RDVT) expanded its stock repurchase capacity, approving an additional $15.0 million under its Stock Repurchase Program, bringing total authorization to $30.0 million. As of November 3, 2025, approximately $18.9 million remained available for repurchases.
The company also furnished a press release announcing financial results for the third quarter ended September 30, 2025. The release was provided as Exhibit 99.1 and is furnished, not filed, under the Exchange Act.
Red Violet, Inc. (RDVT) reported an insider transaction on a Form 4. The Chief Information Officer disposed of 7,034 shares of common stock on 11/03/2025 under transaction code F, indicating shares were withheld to satisfy tax obligations, at a price of $53.63.
Following the transaction, the insider beneficially owned 165,934 shares directly. The disposition was tied to the vesting of RSU tranches from awards approved on October 12, 2022 (third tranche of 10,000 RSUs) and November 4, 2024 (first tranche of 7,875 RSUs).
Outstanding RSUs include 20,000 granted on November 30, 2023, vesting in equal installments on December 1, 2025 and December 1, 2026, and 15,750 granted on November 4, 2024, vesting in equal installments on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) reported a Form 4 for CEO, Director, and Chairman Derek Dubner. On 11/03/2025, he reported a code F disposition of 9,379 common shares at $53.63 per share to satisfy tax obligations upon RSU vesting. Following the transaction, Dubner reported 571,000 shares beneficially owned, held directly.
Per the footnotes, the tax withholding relates to the vesting of the third tranche of 13,333 RSUs from a grant approved on October 12, 2022 and the first tranche of 10,500 RSUs from a grant approved on November 4, 2024. His holdings include 26,666 RSUs (granted November 30, 2023) vesting in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs (granted November 4, 2024) vesting in equal parts on November 1, 2026 and November 1, 2027, each convertible one-for-one into common stock and subject to accelerated vesting under certain circumstances.
Red Violet, Inc. (RDVT) reported an insider transaction by its Chief Financial Officer. On 11/03/2025, the officer disposed of 9,379 shares of common stock at $53.63 via a Code F transaction, which reflects shares withheld by the issuer to cover taxes upon RSU vesting. Following the transaction, the officer beneficially owns 373,163 shares directly and 466 shares indirectly through an IRA.
The tax withholding relates to vesting tranches from prior RSU grants, including a third tranche of 13,333 RSUs (approved 10/12/2022) and a first tranche of 10,500 RSUs (approved 11/04/2024). Footnotes also note 26,666 RSUs granted 11/30/2023 vesting on 12/01/2025 and 12/01/2026, and 21,000 RSUs granted 11/04/2024 vesting on 11/01/2026 and 11/01/2027.
Red Violet (RDVT) President reported a tax-withholding disposition of 9,379 common shares at $53.63 on 11/03/2025 (Transaction Code F) upon RSU vesting. After this administrative transaction, the insider directly beneficially owns 246,078 shares.
The withholding relates to the vesting of the third tranche of 13,333 RSUs from an October 12, 2022 grant and the first tranche of 10,500 RSUs from a November 4, 2024 grant. Outstanding equity awards include 26,666 RSUs granted November 30, 2023, vesting on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted November 4, 2024, vesting on November 1, 2026 and November 1, 2027.
Trigran Investments, Inc. and five associated individuals report a combined holding of 625,970 shares of Red Violet, Inc., representing 4.5% of the outstanding common stock. The filing discloses shared voting power of 576,088 shares and shared dispositive power of 625,970 shares, with no sole voting or dispositive power reported.
The reporting persons state they disclaim beneficial ownership except to the extent of their pecuniary interest and certify the securities were acquired and are held in the ordinary course of business, not for the purpose of changing control. The filing includes an agreement to make a joint filing among the reporting persons.
Red Violet, Inc. announced its financial results for the second quarter ended June 30, 2025 by furnishing a press release and a conference call transcript. The company made both documents available as exhibits to this report to communicate its second-quarter performance, and noted those materials are furnished rather than filed under the Exchange Act. The filing does not include the underlying financial statements or specific earnings figures within the 8-K text itself; the press release and call transcript are provided as Exhibits 99.1 and 99.2 for investors seeking the full results.